High Efficacy of Sofosbuvir/Velpatasvir Plus GS‐9857 for 12 Weeks in Treatment‐Experienced Genotype 1‐6 HCV‐Infected Patients, Including Those Previously Treated with Direct‐Acting Antivirals: 2016 ACG Presidential Poster Award: 868. (October 2016) - Lawitz, Erik; Kowdley, Kris; Curry, Michael; Reau, Nancy; Nguyen, Mindie; Kwo, Paul; Jacobson, Ira M.; Tran, Tram; Nahass, Ronald; Hinestrosa, Frederico; Herring, Robert; Bennett, Michael; et al.